Viral Myocarditis and Dilated Cardiomyopathy as a Consequence-Changing Insights from Advanced Imaging.

[1]  S. Mohiddin,et al.  Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy , 2022, Journal of internal medicine.

[2]  G. Hasenfuss,et al.  Cardiovascular magnetic resonance imaging patterns of acute COVID-19 mRNA vaccine-associated myocarditis in young male patients: A first single-center experience , 2022, Frontiers in Cardiovascular Medicine.

[3]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[4]  R. Kwong,et al.  Multiparametric Cardiovascular Magnetic Resonance Approach in Diagnosing, Monitoring, and Prognostication of Myocarditis. , 2021, JACC. Cardiovascular imaging.

[5]  M. Pyda,et al.  Perimyocardial Injury Specific for SARS-CoV-2-Induced Myocarditis in Comparison With Non-COVID-19 Myocarditis , 2021, JACC: Cardiovascular Imaging.

[6]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[7]  Amit R. Patel,et al.  Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy. , 2021, European Heart Journal-Cardiovascular Imaging.

[8]  L. Maier,et al.  Patients with acute myocarditis and preserved systolic left ventricular function: comparison of global and regional longitudinal strain imaging by echocardiography with quantification of late gadolinium enhancement by CMR , 2021, Clinical Research in Cardiology.

[9]  Eric Y. Yang,et al.  The Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients with Non-Ischemic Cardiomyopathy. , 2021, Circulation.

[10]  J. Garot,et al.  Prognostic Impact of Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance in Myocarditis: A Systematic Review and Meta-Analysis. , 2021, Circulation. Cardiovascular imaging.

[11]  B. Desjardins,et al.  Prognostic Value of Non-Ischemic Ring-Like Left Ventricular Scar in Patients with Apparently Idiopathic Non-Sustained Ventricular Arrhythmias. , 2021, Circulation.

[12]  L. Cooper,et al.  Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy , 2020, Circulation. Heart failure.

[13]  S. Heymans,et al.  Myocarditis and inflammatory cardiomyopathy: current evidence and future directions , 2020, Nature Reviews Cardiology.

[14]  K. Klingel,et al.  Predictors of Mortality in Patients With Biopsy‐Proven Viral Myocarditis: 10‐Year Outcome Data , 2020, Journal of the American Heart Association.

[15]  A. Zangrillo,et al.  Heart and Lung Multimodality Imaging in COVID-19 , 2020, JACC: Cardiovascular Imaging.

[16]  M. Dweck,et al.  Global evaluation of echocardiography in patients with COVID-19 , 2020, European heart journal cardiovascular Imaging.

[17]  G. Pontone,et al.  “Quadruple Rule-Out” With Computed Tomography in a COVID-19 Patient With Equivocal Acute Coronary Syndrome Presentation , 2020, JACC: Cardiovascular Imaging.

[18]  G. Pontone,et al.  Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. , 2019, Journal of the American College of Cardiology.

[19]  J. Jeudy,et al.  Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR? , 2019, Current Cardiology Reports.

[20]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[21]  A. Arai,et al.  Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults , 2018, European heart journal.

[22]  C. Antoniades,et al.  Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. , 2018, JACC. Cardiovascular imaging.

[23]  C. Giannattasio,et al.  Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry , 2018, Circulation.

[24]  D. Corrado,et al.  Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete's Heart by Using Imaging. , 2018, JACC. Cardiovascular imaging.

[25]  R. Blankstein,et al.  Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis , 2018, The International Journal of Cardiovascular Imaging.

[26]  I. Palacios,et al.  Comparison of Utilization Trends, Indications, and Complications of Endomyocardial Biopsy in Native Versus Donor Hearts (from the Nationwide Inpatient Sample 2002 to 2014). , 2018, The American journal of cardiology.

[27]  G. Pontone,et al.  Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.

[28]  J. Cleland,et al.  Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future , 2017, Circulation.

[29]  P. Schlattmann,et al.  Outcome predictors in dilated cardiomyopathy or myocarditis , 2017, European journal of clinical investigation.

[30]  Malte Kelm,et al.  Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis , 2017, Journal of Cardiovascular Magnetic Resonance.

[31]  G. Schuler,et al.  Biventricular endomyocardial biopsy in patients with suspected myocarditis: Feasibility, complication rate and additional diagnostic value. , 2017, International journal of cardiology.

[32]  Christopher A. Miller,et al.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases , 2017, The International Journal of Cardiovascular Imaging.

[33]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[34]  U. Eriksson,et al.  The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[35]  R. Fimmers,et al.  Comprehensive Cardiac Magnetic Resonance for Short‐Term Follow‐Up in Acute Myocarditis , 2016, Journal of the American Heart Association.

[36]  Sabino Iliceto,et al.  Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes , 2016, Circulation. Arrhythmia and electrophysiology.

[37]  P. Steg,et al.  Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. , 2016, International journal of cardiology.

[38]  Matthias Gutberlet,et al.  Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.

[39]  T. Meyer,et al.  Data from a nationwide registry on sports-related sudden cardiac deaths in Germany , 2015, European journal of preventive cardiology.

[40]  G. Barbati,et al.  Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis , 2013, Circulation.

[41]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[42]  S. Russell,et al.  Evaluation of the Role of Endomyocardial Biopsy in 851 Patients With Unexplained Heart Failure From 2000–2009 , 2013, Circulation. Heart failure.

[43]  L. Cooper,et al.  Speckle tracking echocardiography in acute myocarditis , 2013, The International Journal of Cardiovascular Imaging.

[44]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[45]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[46]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[47]  Sandeep Sagar,et al.  Myocarditis , 2012, The Lancet.

[48]  L. Cooper,et al.  Update on myocarditis. , 2012, Journal of the American College of Cardiology.

[49]  K. George,et al.  Diverse Patterns of Myocardial Fibrosis in Lifelong, Veteran Endurance Athletes , 2011, Journal of applied physiology.

[50]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[51]  S. Mavrogeni,et al.  Myocarditis as a complication of influenza A (H1N1): evaluation using cardiovascular magnetic resonance imaging. , 2010, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[52]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[53]  Michael Böhm,et al.  Predictors of Outcome in Patients With Suspected Myocarditis , 2008, Circulation.

[54]  Eloisa Arbustini,et al.  Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[55]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[56]  K. Baughman.  Diagnosis of myocarditis: death of Dallas criteria. , 2006, Circulation.

[57]  H. Rickli,et al.  Long-term outcome of acute myocarditis is independent of cardiac enzyme release. , 2003, International journal of cardiology.

[58]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[59]  B. Strauer,et al.  Cardiac troponin T in patients with clinically suspected myocarditis. , 1997, Journal of the American College of Cardiology.

[60]  A. Jaffe,et al.  Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. , 1997, Circulation.

[61]  A. di Lenarda,et al.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. , 1992, American heart journal.

[62]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[63]  L. Cooper.  Medical Progress Myocarditis , 2009 .

[64]  B. Lewis,et al.  [The new universal definition of myocardial infarction]. , 2009, Harefuah.